【レポートの概要(一部)】
PART 01:Executive summary
• Highlights
PART 02:Scope of the report
• Market overview
• Top-vendor offerings
PART 03:Market research methodology
• Research methodology
• Economic indicators
PART 04:Introduction
• Key market highlights
PART 05:Pipeline portfolio
• Ulcerative colitis
• Crohn’s disease
• IBS
PART 06:Market landscape
• Global gastrointestinal therapeutics market
PART 07:Market segmentation by disease type
• Overview
PART 08:Global IBD therapeutics market
• Global ulcerative colitis drugs market
• Global Crohn’s disease drugs market
• Market segmentation by molecule type
PART 09:Global IBS therapeutics market
PART 10:Global gastrointestinal OTC drugs market
PART 11:Geographical segmentation
• Global gastrointestinal therapeutics market by geography 2015-2020
• Gastrointestinal therapeutics market in Americas
• Gastrointestinal therapeutics market in EMEA
• Gastrointestinal therapeutics market in APAC
PART 12:Market drivers
• Increasing consumption of biologics
• Tentative approval of late stage molecules
• Development of novel therapies using innovative technologies
• Improved diagnostic tools increasing the treatment-seeking population
PART 13:Impact of drivers
PART 14:Market challenges
• Increased consumption of OTC medications
• Unknown etiology of IBD and IBS
• Discontinuation of drugs under development and from the market
PART 15:Impact of drivers and challenges
PART 16:Market trends
• Patient assistance programs
• Emergence of biosimilars
• Rise in self-medication
• Focus on regenerative medicines
• Strategic alliances and M&A
PART 17:Vendor landscape
• Competitive scenario
• Other prominent vendors
PART 18:Key vendor analysis
• AbbVie
• Johnson & Johnson
• Takeda
• Allergan
• UCB
PART 19:Appendix
• List of abbreviations
PART 20:Explore Technavio
[List of Exhibits]
Exhibit 01:Product offerings
Exhibit 02:Global gastrointestinal therapeutics market: Key buying criteria 2015
Exhibit 03:Global gastrointestinal therapeutics market: Key customer segments
Exhibit 04:Global ulcerative colitis therapeutics market: Pipeline portfolio
Exhibit 05:Global Crohn’s disease therapeutics market: Pipeline portfolio
Exhibit 06:Global IBS therapeutics market: Pipeline portfolio
Exhibit 07:Global gastrointestinal therapeutics market snapshot: Developed and emerging markets 2015
Exhibit 08:Global gastrointestinal therapeutics market: Factors affecting growth 2015 and 2020
Exhibit 09:Approval and patent expiries of top selling biologics
Exhibit 10:Global gastrointestinal therapeutics market 2016-2020 ($ billions)
Exhibit 11:Global gastrointestinal disorder therapeutics market segmentation: Growth cycle analysis
Exhibit 12:Five forces analysis
Exhibit 13:Global gastrointestinal therapeutics market by disease type: Revenue share 2015
Exhibit 14:Global gastrointestinal therapeutics market by disease type: Growth lifecycle analysis
Exhibit 15:Global gastrointestinal therapeutics market by disease type 2015-2020
Exhibit 16:Global IBD therapeutics market by type: Revenue share 2015
Exhibit 17:Global IBD therapeutics market by type 2015-2020
Exhibit 18:Global IBD therapeutics market segmentation: Growth lifecycle analysis
Exhibit 19:Global ulcerative colitis drugs market 2015-2020 ($ billions)
Exhibit 20:Global Crohn’s disease drugs market 2015-2020 ($ billions)
Exhibit 21:Global IBD therapeutics market by molecule type 2015
Exhibit 22:Biologics in global IBD therapeutics market 2015-2020 ($ billions)
Exhibit 23:Small molecules in global IBD therapeutics market 2015-2020 ($ billions)
Exhibit 24:Global IBS therapeutics market 2015-2020 ($ billions)
Exhibit 25:Drugs that underwent Rx-to-OTC switch in the US
Exhibit 26:Global gastrointestinal OTC drugs market 2015-2020 ($ billions)
Exhibit 27:Global gastrointestinal therapeutics market by geography 2015-2020
Exhibit 28:Global gastrointestinal therapeutics market by geography 2015 and 2020
Exhibit 29:Global gastrointestinal therapeutics market by geography 2015-2020 ($ billions)
Exhibit 30:Global gastrointestinal therapeutics market by geography: Market share 2015
Exhibit 31:Global gastrointestinal therapeutics market by geography: Disease type 2015
Exhibit 32:Global gastrointestinal therapeutics market by geography: Market growth lifecycle analysis 2015
Exhibit 33:Global gastrointestinal therapeutics market by country: Revenue and growth rate analysis
Exhibit 34:Opportunity analysis of gastrointestinal therapeutics market in Americas
Exhibit 35:Gastrointestinal therapeutics market in Americas 2015-2020 ($ billions)
Exhibit 36:Opportunity analysis of gastrointestinal therapeutics market in EMEA
Exhibit 37:Gastrointestinal therapeutics market in EMEA 2015-2020 ($ billions)
Exhibit 38:Opportunity analysis of gastrointestinal therapeutics market in APAC
Exhibit 39:Gastrointestinal therapeutics market in APAC 2015-2020 ($ billions)
Exhibit 40:Impact of drivers and challenges on global gastrointestinal therapeutics market
Exhibit 41:Biologics for IBD: market share 2012-2022
Exhibit 42:Few biologics under development for gastrointestinal disorders
Exhibit 43:Impact of drivers
Exhibit 44:Rx-to-OTC switch: Promoters and inhibitors
Exhibit 45:Gastrointestinal therapeutics discontinued from development or market
Exhibit 46:Impact of drivers and challenges
Exhibit 47:Global gastrointestinal therapeutics market: Impact assessment of key trends
Exhibit 48:Gastrointestinal therapeutics with patient assistance programs in US
Exhibit 49:Biosimilars under development for gastrointestinal disorders
Exhibit 50:Regenerative medicines for IBD under development
Exhibit 51:Key vendors ranking 2015
Exhibit 52:Key vendors: Geographical presence
Exhibit 53:Market vendors: Competitive scenario 2015-2020
Exhibit 54:AbbVie: Profile
Exhibit 55:AbbVie: Strength analysis
Exhibit 56:AbbVie: Growth strategy matrix
Exhibit 57:AbbVie: Opportunity assessment
Exhibit 58:AbbVie: YoY growth and revenue of HUMIRA 2012-2014 ($ billions)
Exhibit 59:Johnson & Johnson: Profile
Exhibit 60:Johnson & Johnson: Strength analysis
Exhibit 61:Johnson & Johnson: Growth strategy matrix
Exhibit 62:Johnson & Johnson: Opportunity assessment
Exhibit 63:Johnson & Johnson: YoY revenue and growth rate of Remicade 2013-2015 ($ billions)
Exhibit 64:Johnson & Johnson: YoY revenue and growth rate of Simponi/Simponi Aria 2013-2015 ($ billions)
Exhibit 65:Takeda: Profile
Exhibit 66:Takeda: Strength analysis
Exhibit 67:Takeda: Growth strategy matrix
Exhibit 68:Takeda: Opportunity assessment
Exhibit 69:Allergan: Profile
Exhibit 70:Allergan: Strength analysis
Exhibit 71:Allergan: Growth strategy matrix
Exhibit 72:Allergan: Opportunity assessment
Exhibit 73:Allergan: Revenue of gastrointestinal therapeutics 2015 ($ millions)
Exhibit 74:UCB: Profile
Exhibit 75:UCB: Strength analysis
Exhibit 76:UCB: Growth strategy matrix
Exhibit 77:UCB: Opportunity assessment
【レポート販売概要】
■ タイトル:消化器疾患治療薬の世界市場2016-2020■ 英文:Global Gastrointestinal Therapeutics Market 2016-2020
■ 発行日:2016年9月30日
■ 調査会社:Technavio
■ 商品コード:IRTNTR10476
■ 調査対象地域:グローバル
- エタノール(EtOH)の世界市場動向及び予測2015The present report is an essential resource for a one looking for detailed information on the world ethanol market. The report covers data on global, regional and national markets including present and future trends for supply and demand, prices, and downstream industries. In addition to the analytical part, the report provides a range of tables and figures which all together give a true insight i …
- 機能性流体のグローバル市場(2014-2018)About Functional Fluids Functional fluids, which include lubricants, hydraulic fluids, transmission fluids, heat transfer fluids, and metal working fluids, are prepared from base stocks that are of hydro carbon, synthetic or bio in origin. Functional fluids enable high energy, efficiency, productivity, sustainability, and smooth running of end-user businesses. The demand for functional fluids is h …
- 商用車用AMTトランスミッションの世界市場2016-2020About Automated Manual Transmission The global AMT market in commercial vehicles will experience a rapid growth in the wake of stringent environmental regulations and higher demand for fuel efficiency. Globally, EMEA, Americas, and APAC countries are increasingly encouraging companies to come up with new technologies to ensure optimum torque delivery for the flexibility and convenience of driving …
- 厚膜デバイスの世界市場2015-2019About Thick Film Devices Thick film devices are single-layered or multi-layered structures and are made up by the deposition of a formulated paste on a substrate. The substrate can be made of various materials such as ceramic, polymeric, and metallic. The layer deposited on the substrate facilitates electrical, mechanical, or chemical functionality for the device, in which the layer is fabricated. …
- 調理済み食品の世界市場:冷凍食品、冷蔵食品、缶詰食品、乾燥食品About Ready Meals Ready meals are sold pre-cooked to a certain extent, and serve as easy alternatives to food prepared at home. They are promoted and presented by vendors as quick and time-saving alternatives, which requires just heating before consumption. These packaged meals are available in frozen, chilled, canned, or dried forms and for single or two servings. Technavio’s analysts forecast th …
- テレラジオロジーの世界市場:イメージング技術別(X線、コンピューター断層撮影(CT)、超音波、磁気共鳴イメージング(MRI)、核イメージング、蛍光透視法、マンモグラフィー、その他)、技術別(ハードウェア、ソフトウェア、通信・ネットワーク)、エンドユーザー別(病院、外来手術センター、診断センター、その他)The global teleradiology market accounted for $2,709 million in 2017 and is expected to reach $10,621 million by 2025, at a CAGR of 18.4% from 2018 to 2025. Teleradiology is a service that has medical images construed by a radiologist from a distant location. These interpretations are made through several imaging techniques including CT, MRI, ultrasound, nuclear medicine, X-rays, and others, and h …
- 企業用ファイアーウォールの世界市場:ファイアウォールアプライアンス/ソフトウェア/サービスRight security solution is indispensable need of any organization in order to protect their network and infrastructure from continuously evolving cyber threats. The concept of firewall is not new. It is in fact traced down since long with the proliferation of advanced and unknown cyber threats. Since its inception, the firewall market has improved in leaps and bounds to overcome the deficiencies a …
- 乳がん治療薬の世界市場:モノクローナル抗体、ホルモン、化学療法、キナーゼ阻害剤、その他Breast Cancer Therapies – Discover From 2016 What Revenues Are PossibleAre you interested in the breast cancer drug market’s future? If so, you find that sales forecasting from 2016 in our new report. See there what is possible for those products and companies. You also explore trends, results and R&D, discovering opportunities and prospects. Visiongain’s study gives revenue predictions to 2026 at …
- テトラクロロエチレン(PCE)の世界市場予測Perchloroethylene 2014 World Market Outlook and Forecast is an absolutely essential resource for anyone looking for detailed information on the mentioned market. Using a wide range of primary and secondary sources, we combined, analyzed and presented all available data about perchloroethylene market in the all-in-one report issued in a logical and easily accessible format. In addition to the analy …
- 自己輸血装置の世界市場予測(~2024年)“The autotransfusion systems market is projected to grow at a CAGR of 5.0%.”The autotransfusion systems market is projected to reach USD 505 million by 2024 from USD 395 million in 2019, at a CAGR of 5.0%. The growth of this market is driven by the increasing number of surgical procedures, rising number of transplant procedures, advantages of autotransfusion, and scarcity of donated blood/allogeni …
- 先進運転支援システム(ADAS)の世界市場:タイヤ空気圧監視システム(TPMS)、眠気モニターシステム、インテリジェントパーキングアシストシステム(IPAS)、適応走行制御システム、死角物体検出システム、車線逸脱警告システム、適応フロントライティングシステムAdvanced driver assistance systems are intelligent systems which are installed in the vehicle to assist the driver with safe and comfortable driving experience. These systems are used to provide vital information such as traffic congestion level, suggested routes, blockage & closure of roads ahead, and others. In addition, ADAS is also used to analyze the fatigue and distraction of human driver an …
- 尿失禁関連デバイスの世界市場2019-2023About this market The growing prevalence of physical and medical conditions leading to urinary incontinence will further trigger the market’s growth in the forthcoming years. Strong prevalence of the elderly population in both emerging and advanced economies will further surge the incidences of urinary incontinence during the forecast period. Factors including spinal injury, pregnancy, menopause, …
- 超音速ビジネスジェット(SBJ)の世界市場2016-2020About Supersonic Business Jet A supersonic business jet (SBJ) is a small business private carrier, which can accommodate 10 to 12 passengers and can fly at a speed of more than Mach 1. It efficiently reduces the travel time to half, as compared to other conventional business aircraft. Currently, aviation experts such as Airbus, Lockheed Martin, Aerion, HyperMach, and Gulfstream Aerospace develop s …
- エネルギー部門におけるIT支出の世界市場2016-2020:ITサービス、ソフトウェア、ハードウェアAbout IT Spending in Energy Sector IT spending comprises the spending of the enterprise on the procurement of IT solutions and services in the energy sector. Energy firms like the oil and gas companies along with the power companies require IT solutions such as on-premises of cloud-based software solutions, networking devices, equipment, and IT support services. Technavio’s analysts forecast the g …
- カーボンナノチューブ市場(タイプ別、アプリケーション別、地域別分析、グローバルトレンド、予測)Carbon nanotubes are minuscule allotropes of carbon having sizes to the scale of nanometers. The physical, electrical, and thermal properties make these a special material for number of applications. CNTs have very high tensile strength, excellent electrical conductivity, and the ability to bear high working temperatures. However, not withstanding some challenges like high cost of production and i …